Clinical Trials for Recurrent Non-Hodgkin Lymphoma

Find clinical trials for recurrent non-hodgkin lymphoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

NCT ID: NCT05627245

This clinical trial is investigating the safety and effectiveness of two anti-cancer drugs, tazemetostat and belinostat, for patients with certain types of lymphomas that have come back after treat...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Oklahoma City, Oklahoma, United States +8 more

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

NCT ID: NCT05418088

This clinical trial is studying a new treatment for certain types of blood cancers, specifically targeting those that have come back or have not responded to previous treatments. The treatment invo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Columbus, Ohio, United States

Personalized NK Cell Therapy in CBT

NCT ID: NCT02727803

This clinical trial is looking at a new treatment called personalized natural killer (NK) cell therapy for patients with certain types of blood cancers, including leukemia, lymphoma, and myelodyspl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

NCT ID: NCT04640779

This clinical trial is studying a combination of two medications, low-dose selinexor and choline salicylate, to find out their safety and the best dose to use for treating patients with certain typ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

NCT ID: NCT05077527

This clinical trial is studying a new treatment called CAR-T therapy, specifically axicabtagene ciloleucel, for patients who have aggressive types of B-cell non-Hodgkin lymphoma related to HIV. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, New York, New York, United States

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT ID: NCT04851119

This clinical trial is studying a new medication called tegavivint, which is being tested to see if it can help patients with certain types of solid tumors that have either come back after treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Saint Louis, Missouri, United States +20 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions